Shopping Cart
Remove All
Your shopping cart is currently empty
Synonyms: PVRR3, PVRL3, PRR3, PPR3, NECTIN-3, NECTIN3, CDW113
Anti-CD113 Monoclonal Antibody
(9Q238)
| Pack Size | Price | USA Stock | Global Stock | Quantity |
|---|---|---|---|---|
| 20 µL | Inquiry | 7-10 days | 7-10 days | |
| 50 µL | Inquiry | 7-10 days | 7-10 days | |
| 100 µL | Inquiry | 7-10 days | 7-10 days |
| Description | Anti-CD113 Monoclonal Antibody (9Q238) is a Mouse antibody targeting CD113. Anti-CD113 Monoclonal Antibody (9Q238) can be used in FCM. |
| Synonyms | PVRR3, PVRL3, PRR3, PPR3, NECTIN-3, NECTIN3, CDW113 |
| Ig Type | IgG1 |
| Clone | 9Q238 |
| Reactivity | Human |
| Application | |
| Recommended Dose | FCM: 1/200-1/400 |
| Antibody Type | Monoclonal |
| Host Species | Mouse |
| Construction | Hybridoma Monoclonal Antibody |
| Purification | Purified by protein A or protein G |
| Appearance | Liquid |
| Formulation | PBS with 0.05% sodium azide |
| Concentration | 1 mg/ml |
| Research Background | This gene encodes a member of the nectin family of proteins, which function as adhesion molecules at adherens junctions. This family member interacts with other nectin-like proteins and with afadin, a filamentous actin-binding protein involved in the regulation of directional motility, cell proliferation and survival. This gene plays a role in ocular development involving the ciliary body. Mutations in this gene are believed to result in congenital ocular defects. Alternative splicing results in multiple transcript variants. [provided by RefSeq, Aug 2011] |
| Conjucates | Unconjugated |
| Immunogen | Purified recombinant fragment of human CD113 (AA: extra 282-404) expressed in E. Coli. |
| Antigen Species | Human |
| Gene Name | NECTIN3 |
| Gene ID | |
| Protein Name | Nectin-3 |
| Uniprot ID |
| Stability & Storage | Store at -20°C or -80°C for 12 months. Avoid repeated freeze-thaw cycles. |
| Transport | Shipping with blue ice. |
| Size | Quantity | Unit Price | Amount | Operation |
|---|

Copyright © 2015-2026 TargetMol Chemicals Inc. All Rights Reserved.